CraigHarryReynoldsMD

Oncology • Ocala, FL

Physician

Join to view full profile

Dr. Reynolds is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Reynolds' full profile

Already have an account?

Office
Florida Cancer Specialists (OCC)
4945 SW 49th Place
Ocala, FL 34474
Phone+1 352-237-9430

Fax+1 352-237-9698
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1990 - 1993
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1987 - 1990
Washington University in St. Louis School of MedicineClass of 1987

Certifications & Licensure

FL State Medical License 1993 - 2026
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Sunitinib Non Small Cell Lung Cancer Patients Over 70 Start of enrollment: 2009 Feb 01
Completed
Phase 2
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01
Completed
Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2012 Feb 01
Unknown status
Phase 1, Phase 2
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
Completed
Phase 3
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

91 citations
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.
David M. Waterhouse, Edward B. Garon, Jason C. Chandler, Michael McCleod, Maen A. Hussein, Robert M. Jotte, Leora Horn, Davey B. Daniel, George P. Keogh, Ben C. Creela...> ;Journal of Clinical Oncology. 2020 Sep 10
11 citations
Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational Study
Craig W. Reynolds, Elizabeth T. Masters, Jenny Black-Shinn, Marley Boyd, Jack Mardekian, Janet L. Espirito, Marc D. Chioda> ;Journal of Clinical Medicine. 2018 May 29
167 citations
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advance...
David R. Spigel, Craig W. Reynolds, David M. Waterhouse, Edward B. Garon, Jason C. Chandler, Sunil Babu, Paul Thurmes, Alexander I. Spira, Robert M. Jotte, Jin Zhu, We...> ;Journal of Thoracic Oncology. 2018 May 1
13 citations
Safety profile of nivolumab administered as 30-min infusion: analysis of data from CheckMate 153
David M. Waterhouse, Leora Horn, Craig H. Reynolds, David R. Spigel, Jason C. Chandler, Tarek Mekhail, Mohamed K. Mohamed, Ben C. Creelan, Kenneth B. Blankstein, Petro...> ;Cancer Chemotherapy and Pharmacology. 2018 Feb 13
110 citations
Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer
Mark A. Socinski, Coleman K. Obasaju, David R. Gandara, Fred R. Hirsch, Philip Bonomi, Paul A. Bunn, Edward S. Kim, Corey J. Langer, Ronald B. Natale, Silvia Novello, ...> ;Journal of Thoracic Oncology. 2017 Nov 23
11 citations
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
Fred R. Hirsch, Keith M. Kerr, Paul A. Bunn, Edward S. Kim, Coleman K. Obasaju, Maurice Pérol, Philip Bonomi, Jeffrey D. Bradley, David R. Gandara, James R. Jett, Core...> ;Clinical Lung Cancer. 2018 Jul 1
10 citations
Caring for the Older Population With Advanced Lung Cancer
Carolyn J. Presley, Craig H. Reynolds, Corey J. Langer> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2017 Jan 1
45 citations
Incremental innovation and progress in advanced squamous cell lung cancer: current status and future impact of treatment.
Corey J. Langer, Coleman K. Obasaju, Paul A. Bunn, Philip Bonomi, David R. Gandara, Fred R. Hirsch, Edward S. Kim, Ronald B. Natale, Silvia Novello, Luis Paz-Ares, Mau...> ;Journal of Thoracic Oncology. 2016 Dec 1
PS01.59: CheckMate 370: A Master Protocol of Phase 1/2 Studies of Nivolumab as Maintenance or First-Line ± Standard-of-Care Therapies in Advanced NSCLC: Topic: Medical...
Blumenschein G, Chandler J, Garon EB, Waterhouse D, Goldman JW, Gunuganti VK, Boccia R, Spigel D, Glaspy J, Berry DA, Korytowsky B, Zhu J, Lin WH, Bennett K, Reynolds C> ;J Thorac Oncol. 2016-11-01
92 citations
Clinicopathologic Features of Advanced Squamous NSCLC
Mark A. Socinski, Coleman K. Obasaju, David R. Gandara, Fred R. Hirsch, Philip Bonomi, Paul A. Bunn, Edward S. Kim, Corey J. Langer, Ronald B. Natale, Silvia Novello, ...> ;Journal of Thoracic Oncology. 2016 Sep 1
24 citations
Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations
Benjamin Levy, Marc D. Chioda, Dana Herndon, John W. Longshore, Mohamed K. Mohamed, Sai-Hong Ignatius Ou, Craig H. Reynolds, Jaspal Singh, Ignacio I. Wistuba, Paul A. ...> ;The Oncologist. 2015 Oct 1
4 citations
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Pa...
Craig H. Reynolds, Jyoti D. Patel, Edward B. Garon, Mark R. Olsen, Philip Bonomi, Ramaswamy Govindan, Eduardo J. Pennella, Jingyi Liu, Susan C. Guba, Shi Li, David R. ...> ;Clinical Lung Cancer. 2015 May 1
18 citations
Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizum...
David R. Spigel, Jyoti D. Patel, Craig H. Reynolds, Edward B. Garon, Robert C. Hermann, Ramaswamy Govindan, Mark R. Olsen, Katherine B. Winfree, Jian Chen, Jingyi Liu,...> ;Journal of Thoracic Oncology. 2015 Feb 1
Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomise...
Kim, E. S.,Neubauer, M.,Cohn, A.,Schwartzberg, L.,Garbo, L.,Caton, J.,Robert, F.,Reynolds, C.,Katz, T.,Chittoor, S.,Simms, L.,Saxman, S.> ;Lancet Oncol.. 2013 Nov 16
273 citations
PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carbo...
Jyoti D. Patel, Mark A. Socinski, Edward B. Garon, Craig H. Reynolds, David R. Spigel, Mark R. Olsen, Robert C. Hermann, Robert M. Jotte, Thaddeus Beck, Donald A. Rich...> ;Journal of Clinical Oncology. 2013 Dec 1
11 citations
Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: results of a Phase II trial.
Craig W. Reynolds, Alexander I. Spira, Larry Gluck, Suzanne E. Mueller, Feng Zhan, Kristi A. Boehm, Lina Asmar> ;Investigational New Drugs. 2013 Jun 13
A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced...
Carter DL, Garfield D, Hathorn J, Mundis R, Boehm KA, Ilegbodu D, Asmar L, Reynolds C> ;Clin Lung Cancer. 2012-05-01
Results of a phase II study of single-agent sunitinib in elderly non-small cell lung cancer patients.
Reynolds C, Spira AI, Gluck WL, Pluenneke RE, Boehm KA, Zhan F, Asmar L> ;J. Clin. Oncol.. 2011-05-20
20 citations
A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
Charles Weissman, Craig H. Reynolds, Marcus A. Neubauer, Sharon Pritchard, Svetlana Kobina, Lina Asmar> ;Journal of Thoracic Oncology. 2011 Feb 1
Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.
Reynolds C, Barrera D, Jotte R, Spira AI, Weissman C, Boehm KA, Pritchard S, Asmar L> ;J Thorac Oncol. 2009-12-01
141 citations
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer
Craig W. Reynolds, Coleman K. Obasaju, Michael J. Schell, Xueli Li, Zhong Zheng, David Boulware, John R. Caton, Linda Cheryl DeMarco, Mark A. O'Rourke, Gail S. Wright,...> ;Journal of Clinical Oncology. 2009 Dec 1
Results from a phase I safety lead-in study investigating the combination of erlotinib and the histone deacetylase inhibitor entinostat in patients with advanced NSCLC.
Konduri K, Spira AI, Jotte RM, Boyd T, Boyd T, Gaffar YA, Reynolds C, Witta SE> ;J. Clin. Oncol.. 2009-05-20
Results of a randomized phase II trial of amrubicin (AMR) versus topotecan (Topo) in patients with extensive-disease small cell lung cancer (ED-SCLC) sensitive to firs...
Jotte R, Conkling P, Reynolds C, Klein L, Fitzgibbons JF, McNally R, Renschler M, Oliver JW> ;J. Clin. Oncol.. 2009-05-20
Ductal carcinoma in situ of the breast and gene expression markers for prediction of invasive recurrence.
McKean HA, Reynolds C, Hoskin TL, Suman VJ, Grant CS, Erlander MG, Ma X, Ingle J, Goetz MP> ;J. Clin. Oncol.. 2009-05-20
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lu...
Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam ...> ;J. Clin. Oncol.. 2008-12-10
Join now to see all

Press Mentions

American Oncology Network, LLC Expands Board with Physician AppointmentsSeptember 13th, 2019
Physicians with Florida Cancer Affiliates Honored for Contributions to Clinical ResearchMarch 8th, 2016